Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.37
(-10.36%)
USD 0.37
(-10.36%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.88 Million USD | 130.42% |
| 2022 | 2.55 Million USD | 46.55% |
| 2021 | 1.74 Million USD | 242.08% |
| 2020 | 509.52 Thousand USD | 0.0% |
| 2018 | 568.63 Thousand USD | 207.12% |
| 2017 | 185.15 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.38 Million USD | 7.97% |
| 2024 Q2 | 1.48 Million USD | 7.21% |
| 2023 Q2 | 1.46 Million USD | -5.12% |
| 2023 Q1 | 1.54 Million USD | 108.53% |
| 2023 Q4 | 1.28 Million USD | -19.9% |
| 2023 Q3 | 1.59 Million USD | 9.11% |
| 2023 FY | 5.88 Million USD | 130.42% |
| 2022 Q3 | 821.46 Thousand USD | 132.3% |
| 2022 Q2 | 353.62 Thousand USD | -44.61% |
| 2022 Q1 | 638.39 Thousand USD | -35.42% |
| 2022 FY | 2.55 Million USD | 46.55% |
| 2022 Q4 | 740.78 Thousand USD | -9.82% |
| 2021 Q1 | 176.08 Thousand USD | 0.0% |
| 2021 FY | 1.74 Million USD | 242.08% |
| 2021 Q4 | 988.53 Thousand USD | 308.29% |
| 2021 Q3 | 242.11 Thousand USD | -28.0% |
| 2021 Q2 | 336.25 Thousand USD | 90.96% |
| 2020 FY | 509.52 Thousand USD | 0.0% |
| 2018 FY | 568.63 Thousand USD | 207.12% |
| 2017 FY | 185.15 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | 28.685% |
| Alpha Teknova, Inc. | 45.85 Million USD | 87.166% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 96.997% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 86.878% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 96.303% |
| Cosmos Health Inc. | 26.18 Million USD | 77.52% |
| Journey Medical Corporation | 54.59 Million USD | 89.219% |
| Embecta Corp. | 528.4 Million USD | 98.886% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 97.835% |
| Dynavax Technologies Corporation | 219.14 Million USD | 97.314% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 99.002% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 98.197% |
| PainReform Ltd. | 9.58 Million USD | 38.59% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 55.156% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 55.156% |
| SCYNEXIS, Inc. | 51.84 Million USD | 88.648% |
| Safety Shot Inc | 12.1 Million USD | 51.398% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -91.763% |
| Procaps Group, S.A. | 199.47 Million USD | 97.049% |
| Theratechnologies Inc. | 72.75 Million USD | 91.911% |
| Harrow Health, Inc. | 89.97 Million USD | 93.459% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | 37.692% |
| Biofrontera Inc. | 39.95 Million USD | 85.271% |
| DURECT Corporation | 43.71 Million USD | 86.536% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 98.887% |
| Cronos Group Inc. | 96.7 Million USD | 93.914% |
| OptiNose, Inc. | 85.1 Million USD | 93.084% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 97.464% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 84.968% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 161.558% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 98.126% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | 39.516% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 86.326% |
| Radius Health, Inc. | 265.92 Million USD | 97.787% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 57.48% |
| ProPhase Labs, Inc. | 37.85 Million USD | 84.451% |
| Phibro Animal Health Corporation | 260.29 Million USD | 97.739% |
| Procaps Group S.A. | 187.24 Million USD | 96.857% |
| Alvotech | 285.43 Million USD | 97.938% |
| TherapeuticsMD, Inc. | 9.82 Million USD | 40.096% |
| Viatris Inc. | 5.96 Billion USD | 99.901% |
| Rockwell Medical, Inc. | 15.37 Million USD | 61.717% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 90.164% |
| SIGA Technologies, Inc. | 22.04 Million USD | 73.3% |
| Tilray Brands, Inc. | 251.35 Million USD | 97.658% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 87.998% |
| Shineco, Inc. | 17.94 Million USD | 67.208% |
| PetIQ, Inc. | 192.72 Million USD | 96.946% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -47.466% |
| Incannex Healthcare Limited | 30.05 Million USD | 80.416% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.631% |
| Alimera Sciences, Inc. | 62.64 Million USD | 90.604% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -671.886% |
| Assertio Holdings, Inc. | 368.58 Million USD | 98.403% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 66.951% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 72.197% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 72.03% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 96.432% |
| Hempacco Co., Inc. | 7.59 Million USD | 22.522% |
| Talphera, Inc. | 11.99 Million USD | 50.929% |
| Alvotech | 285.43 Million USD | 97.938% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 95.817% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 98.294% |
| Currenc Group, Inc. | 24 Million USD | 75.479% |
| Kamada Ltd. | 45.42 Million USD | 87.044% |
| Indivior PLC | 911 Million USD | 99.354% |
| Evoke Pharma, Inc. | 12.4 Million USD | 52.573% |
| Flora Growth Corp. | 10.57 Million USD | 44.366% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 72.03% |
| Evolus, Inc. | 189.75 Million USD | 96.898% |
| HUTCHMED (China) Limited | 436.23 Million USD | 98.651% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 96.182% |
| Akanda Corp. | 3.48 Million USD | -68.955% |